US 10087252
Methods and compositions for treating and preventing disease associated with αvβ5 integrin
granted A61KA61K2039/505A61P
Quick answer
US patent 10087252 (Methods and compositions for treating and preventing disease associated with αvβ5 integrin) held by The Regents of the University of California expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Oct 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/505, A61P, A61P29/00, A61P31/00